Gracell Biotechnologies Inc. (GRCL) — Defensive Interval Ratio

Latest as of September 2023: 48 days

Gracell Biotechnologies Inc. (GRCL) has a Defensive Interval Ratio of 48 days as of September 2023. Defensive assets of $30.46 Million (cash $-, short-term investments $30.46 Million, receivables $-) cover 48 days of daily cash needs of $628.70K/day. Check GRCL asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Defensive Interval Ratio

48 days
Days of operational coverage

Defensive Assets

$30.46 Million
Cash + ST Investments + Receivables

Daily Cash Need

$628.70K
Current Liabilities ÷ 365

Current Liabilities

$229.48 Million
USD

Gracell Biotechnologies Inc. Defensive Interval Ratio (2018–2022)

This chart shows how Gracell Biotechnologies Inc.'s Defensive Interval Ratio has evolved across 5 annual periods from 2018 to 2022. As of September 2023, the ratio stands at 48 days, meaning defensive assets of $30.46 Million can fund 48 days of operations without new revenue. See Gracell Biotechnologies Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Annual Defensive Interval Ratio for Gracell Biotechnologies Inc. (2018–2022)

The table below presents the year-by-year Defensive Interval Ratio for Gracell Biotechnologies Inc. from 2018 to 2022, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see total assets of Gracell Biotechnologies Inc..

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2022 49 days $29.89 Million $604.50K/day $- $3.56 Million ▼ -55 days
2021 104 days $44.30 Million $424.99K/day $- $3.62 Million ▼ -90 days
2020 194 days $49.70 Million $255.78K/day $- $18.74 Million ▼ -167 days
2019 361 days $17.97 Million $49.77K/day $- $4.20 Million ▼ -4947 days
2018 5308 days $108.20 Million $20.38K/day $- $102.00 Million
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)